Terms: = Gastric cancer AND DICER1, Dicer, 23405, ENSG00000100697, KIAA0928, HERNA, Q9UPY3, K12H4_8-LIKE AND Treatment
5 results:
1. dicer-AS1 functions as competing endogenous RNA that targets CSR1 by sponging microRNA-650 and suppresses gastric cancer progression.
An J; Guo X; Yan B
J Int Med Res; 2021 Sep; 49(9):3000605211041466. PubMed ID: 34586953
[TBL] [Abstract] [Full Text] [Related]
2. dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2.
Wu J; Zhao Q; Zhao Y; Zhang X; Tian Y; Guo Z
Sci Rep; 2021 Mar; 11(1):6993. PubMed ID: 33772068
[TBL] [Abstract] [Full Text] [Related]
3. Efficient Colonic Delivery of DsiRNA by Pectin-Coated Polyelectrolyte Complex Nanoparticles: Preparation, Characterization and Improved gastric Survivability.
Hussain Z; Katas H; Yan SL; Jamaludin D
Curr Drug Deliv; 2017; 14(7):1016-1027. PubMed ID: 28240178
[TBL] [Abstract] [Full Text] [Related]
4. Biogenesis of Epstein-Barr virus microRNAs.
Kim DN; Lee SK
Mol Cell Biochem; 2012 Jun; 365(1-2):203-10. PubMed ID: 22350759
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting dicer1 in gastric cancer.
Li X; Zhang Y; Shi Y; Dong G; Liang J; Han Y; Wang X; Zhao Q; Ding J; Wu K; Fan D
J Cell Mol Med; 2011 Sep; 15(9):1887-95. PubMed ID: 21029372
[TBL] [Abstract] [Full Text] [Related]
